Company Monitoring Page for Roche

latest headlines for company on cafepharma

Disruptor of the Year: The Federal Trade Commission
Biopharma Dive
Mon, 12/9/19 - 11:16 pm
Tags:
FTC, M&A, Roche, Spark Therapeutics
ASH: Roche bispecific delivers for hard-to-treat lymphoma patients failed by CAR-Ts
Fierce Biotech
Mon, 12/9/19 - 09:48 am
Tags:
Roche, ASH2019, non-Hodgkin lymphoma, mosunetuzumab
ASH: AbbVie, Roche pad their case for fixed-duration Venclexta use in CLL
Fierce Pharma
Sun, 12/8/19 - 10:12 pm
Tags:
AbbVie, Roche, CLL, ASH2019, Venclexta
FDA approves Roche’s MRSA test, allowing for faster screening
Pharmaforum
Fri, 12/6/19 - 09:55 am
Tags:
FDA, Roche, MRSA, diagnostics, cobas vivoDx
Novartis pulls rival to Roche’s risdiplam in SMA, says market limited
Pharmaforum
Fri, 12/6/19 - 09:51 am
Tags:
Novartis, Roche, SMA, risdiplam, branaplam
Roche gets FDA nod for Tecentriq plus chemotherapy to treat metastatic NSCLC
Pharmaceutical Business Review
Wed, 12/4/19 - 10:20 am
Tags:
Roche, Tecentriq, metastatic non-squamous non-small cell lung cancer, FDA
Roche under fire again: Mylan launches Herceptin copycat in latest blow to blockbuster trio
Fierce Pharma
Tue, 12/3/19 - 10:02 am
Tags:
Roche, Mylan, Herceptin, biosimilar, cancer, oncology, Ogivri
Roche trumpets data for Soliris rival in NMOSD after US, EU filings
Pharmaforum
Mon, 12/2/19 - 10:34 am
Tags:
Roche, satralizumab, neuromyelitis optica spectrum disorder, NMOSD
The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More
Yahoo/Benzinga
Mon, 12/2/19 - 09:42 am
Tags:
ASH2019, Roche, Bristol-Myers Squibb, Acadia Pharmaceuticals, Biogen, Cassava Sciences, Alector, GW Pharma, Magenta Therapeutics, Fortress Biotech, Mustang Bio, Bluebird Bio
Drugs firms make massive discounts to get reimbursement in China
Pharmaforum
Fri, 11/29/19 - 02:33 pm
Tags:
Roche, Novartis, China, reimbursement
Roche's flu med Xofluza drives drug resistance and may be a bad choice for kids, study says
Fierce Pharma
Wed, 11/27/19 - 12:34 pm
Tags:
Roche, Genentech, Xofluza, pediatrics
Roche's Xofluza may give rise to resistant strains, raising fears of a 'worst case scenario'
Endpoints
Tue, 11/26/19 - 11:39 pm
Tags:
Roche, Xofluza, Japan, Shionogi, Flu, influenza
Roche, PTC will now get an FDA decision on their SMA drug in 6 months — facing off with Biogen, Novartis
Endpoints
Mon, 11/25/19 - 09:52 am
Tags:
Roche, PTC Therapeutics, SMA, risdiplam, Biogen, Spinraza
Roche shows Tecentriq/Avastin combo helps liver cancer patients live longer
Endpoints
Mon, 11/25/19 - 09:47 am
Tags:
Roche, Tecentriq, Avastin, liver cancer, China, Bayer, Nexavar, clinical trials
Which asthma biologic do docs prefer? It's not that simple: analyst
Fierce Pharma
Sat, 11/23/19 - 03:47 pm
Tags:
asthma, Roche, Novartis, Xolair, Sanofi, Regeneron, Dupixent, physicians
Put on hold music: Roche delays Spark buyout for the 9th — and quite possibly not the last — time
Endpoints
Fri, 11/22/19 - 10:37 am
Tags:
Roche, M&A, Spark Therapeutics
The Week Ahead In Biotech: Clinical Readouts In Focus As Earnings Wind Down
Yahoo/Benzinga
Sun, 11/17/19 - 08:47 pm
Tags:
AHA, The Medicines Company, Intrexon, Alnylam, Pieris, Roche
Roche buys U.S. drugmaker Promedior for up to $1.4 billion to get lung drug
Reuters
Sat, 11/16/19 - 12:01 am
Tags:
Roche, Promedior, idiopathic pulmonary fibrosis, M&A
Five drugs, including two Novartis therapies, win EMA endorsement
Endpoints
Fri, 11/15/19 - 12:22 pm
Tags:
EMA, Europe, Novartis, Mayzent, Isturisa, Roche, Polivy, Jazz Pharma, Sunosi, Rigel Pharma, Tavlesse
Roche's Chugai claims Alexion co-opted its patented tech in building Ultomiris
Fierce Pharma
Wed, 11/13/19 - 11:24 pm
Tags:
Alexion, Chugai, Roche, Ultomiris, patents

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.